Cargando…

Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome

PURPOSE: The TELEACE study showed reductions in tumor size in patients with neuroendocrine tumors, receiving telotristat ethyl in US clinical practice. Here, we report progression-free survival, time to tumor progression, changes in carcinoid syndrome symptoms, and indictors of overall health. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metz, David C, Liu, Eric, Joish, Vijay N, Huynh, Lynn, Totev, Todor I, Duh, Mei Sheng, Seth, Kiernan, Giacalone, Susan, Lapuerta, Pablo, Morse, Michael A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548219/ https://www.ncbi.nlm.nih.gov/pubmed/33116830 http://dx.doi.org/10.2147/CMAR.S276519

Ejemplares similares

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study
por: Morse, Michael A, et al.
Publicado: (2020)

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World
por: Strosberg, Jonathan, et al.
Publicado: (2019)

In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension
por: Jiang, Wenjun, et al.
Publicado: (2018)

Telotristat ethyl for carcinoid syndrome diarrhoea
Publicado: (2019)

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
por: Pavel, Marianne, et al.
Publicado: (2018)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)

Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study
por: Kulke, Matthew H, et al.
Publicado: (2021)

Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
por: Dillon, Joseph S., et al.
Publicado: (2020)

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes
por: Saavedra, Cristina, et al.
Publicado: (2019)

Developments in the treatment of carcinoid syndrome – impact of telotristat
por: Chan, David L, et al.
Publicado: (2018)

Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome
por: Halperin, Daniel M., et al.
Publicado: (2019)

Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study
por: Halperin, Daniel M., et al.
Publicado: (2018)

Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach
por: Gelhorn, Heather L., et al.
Publicado: (2016)

Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors
por: Li, Daneng, et al.
Publicado: (2022)

Value of transfusion independence in severe aplastic anemia from patients’ perspectives – a discrete choice experiment
por: Pickard, A. Simon, et al.
Publicado: (2018)

The journey from gene knockout to clinical medicine: telotristat and sotagliflozin
por: Rendell, Marc S
Publicado: (2019)

Direct costs of carcinoid syndrome diarrhea among adults in the United States
por: Dasari, Arvind, et al.
Publicado: (2019)

MON-630 Elevating the Patient Voice in Type 1 Diabetes Clinical Trials: A Comparison of In-Depth Exit Interviews and Diabetes-Specific Questionnaires
por: Ervin, Claire, et al.
Publicado: (2020)

New Developments in the Treatment of Neuroendocrine Tumours – RADIANT-4, NETTER-1 and Telotristat Etiprate
por: Sbardella, Emilia, et al.
Publicado: (2016)

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
por: Hudgens, Stacie, et al.
Publicado: (2019)

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Marital Status and Survival in Patients with Carcinoid Tumors
por: Greenleaf, Erin K., et al.
Publicado: (2016)

"Carcinoide" /
por: Selem Zacarias, Anuar Antonio
Publicado: (1988)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

Synchronous Duodenal Carcinoid and Adenocarcinoma of the Colon
por: Gao, Limin, et al.
Publicado: (2012)

Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors
por: Cai, Beilei, et al.
Publicado: (2017)

Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female
por: Cogen, Jonathan D., et al.
Publicado: (2016)

Primary Mesenteric Carcinoid Tumor Presenting with Carcinoid Syndrome
por: Shogbesan, Oluwaseun, et al.
Publicado: (2018)

Relatively Long Survival in Hepatocellular Carcinoma Presenting With Carcinoid Syndrome
por: Nwokediuko, Sylvester Chuks, et al.
Publicado: (2010)

NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids
por: Gagliardi, Irene, et al.
Publicado: (2021)

External Validation of a Prognostic Score for Survival in Lung Carcinoids
por: Chiappetta, Marco, et al.
Publicado: (2022)

Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid
por: Li, Sijian, et al.
Publicado: (2022)

Malignant metastatic carcinoid presenting as brain tumor
por: Sundar, I. Vijay, et al.
Publicado: (2016)

The Carcinoid Syndrome
por: Strahan, Jack
Publicado: (1961)

Carcinoid of the Appendix
por: Guha, A. C., et al.
Publicado: (1952)

The Carcinoid Syndrome
Publicado: (1973)

Primary Testicular Carcinoid Tumor presenting as Carcinoid Heart Disease
por: Chikkaraddi, Manjunath L., et al.
Publicado: (2015)

Cases in a series of carcinoid syndrome and carcinoid heart disease
por: Mamotabo, R Matshela
Publicado: (2018)

Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
por: Gounder, Mrinal M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_em27h4a4r0lrtbu9m0t9j3uqf3